Lilly stomach-cancer drug helps survival, study finds
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
Bloomberg News
Articles
Notre Dame revival brings revenue bonanza to football foes
Notre Dame’s football squad is undefeated after five games for the first time in a decade. That’s good news for their opponents: The team is even more of a draw on the road for fans and sponsors.
WellPoint reorganizes into four business units
Separate Medicare and Medicaid divisions each will sell plans for those government-backed insurance programs. Another will handle commercial and individual business, and a specialty unit will provide dental, vision and disability coverage.
Lawmakers question Abound loan, citing quality issues
House Republicans want more information about a $400 million loan guarantee from the U.S. Energy Department to Abound Solar Inc., citing reports that significant “technological difficulties” with the company’s solar panels were known before the aid was approved.
Cummins shares slide on job cuts, lower forecast
Shares in Cummins Inc. saw their biggest one-day drop in three months Wednesday after the Columbus-based engine maker lowered its forecasts for revenue and profit and said it expects to cut as many as 1,500 jobs by the end of the year.
Lilly, Roche drugs chosen for Alzheimer’s prevention trial
Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.
Lilly counting on diabetes products to challenge larger rivals
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
Amerigroup delays vote on $4.9B WellPoint acquisition
Amerigroup Corp. officials agreed to delay a shareholder vote on WellPoint Inc.’s $4.9 billion buyout offer to resolve investors’ claims they were being shortchanged in the deal, the company said in a securities filing.
Biglari agrees to antitrust fine in Cracker Barrel deal
The chain-restaurant operator that owns Indianapolis-based Steak n Shake has agreed to pay $850,000 to settle procedural antitrust violations stemming from its purchase of shares in Cracker Barrel Old Country Store Inc.
WellPoint hires Chicago-based search firm to find CEO
Chicago-based recruiting firm Spencer Stuart & Associates Ltd. has previously led executive and board director hunts for companies including Facebook Inc., Comcast Corp., Talbots Inc. and Hewlett-Packard Co.
Lilly competitor Novo investing $100M in China
Novo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.
WellPoint says CEO search to take three to six months
WellPoint is seeking a replacement for former CEO Angela Braly, who stepped down Aug. 28 amid shareholder discontent. The company plans to hire a search firm within the next week.
Luxury-outlet strategy puts Simon on top of mall industry
Luxury outlet malls—where upscale retailers such as Coach Inc. and Michael Kors Holdings Ltd. hawk discount goods—are now the main source of expansion for the Indianapolis-based real estate investment trust, the country’s largest.
Indiana ethanol plant resumes operations
Valero Energy Corp., the third-largest U.S. ethanol producer, has restarted distilleries in Nebraska and Indiana, as profit margins for the fuel improved.
Big-time college sports leadership still a man’s world
Forty years after the U.S. government’s Title IX law required equal athletic opportunities for men and women, just four women are in charge at the 120 sports departments in NCAA football’s top tier.
Chinese PC giant to buy Carmel software firm Stoneware
Lenovo Group said the purchase of the 67-employee company would "enhance and expand" its cloud computing business.
Investor still pushing for Simon to buy rival despite opposition
Brookfield Asset Management Inc. is keeping a tight grip on its stake in General Growth Properties Inc. in a bet the second-largest U.S. mall owner is better off as an independent company that will jump in value.
Firm seeks commercialization of defense innovations
A Boston-based investment firm says it has reached agreements aimed at commercializing innovations from four Defense Department laboratories, including the Naval Surface Warfare Center's Crane Division in Indiana.
Simon exec: There’s ‘no interest’ in buying General Growth
A Simon Property Group Inc. executive said that the largest U.S. mall owner isn’t trying to acquire competitor General Growth Properties Inc., which announced Monday that it won’t put itself up for sale.
General Growth rejects call for sale of company to Simon
General Growth Properties Inc., the second-largest U.S. shopping-mall owner, rejected investor Bill Ackman’s request to put itself up for sale and said it will remain independent.